This opportunity uses the R21 Exploratory/Developmental Research Grants funding mechanism.
The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited (rapid) funding mechanism for research on Zika virus (ZIKV) and its complications.
Funding & Duration
Direct costs are limited to $275,000 over an R21 two-year period.
The maximum period of the project is 2 years.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Applications will be accepted on a rolling basis, beginning on April 20, 2016.
For this round:
- Applications must be submitted for internal review by 6 April 2016
- The University’s Grant Application Cover Sheet must accompany your application
- Grants Officer: Dr Don McMaster
- Email: firstname.lastname@example.org